Literature DB >> 25839916

Impact of specialist neurovascular care in subarachnoid haemorrhage.

Assad U Khan1, Louise Dulhanty1, Andy Vail2, Pippa Tyrrell3, James Galea4, Hiren C Patel5.   

Abstract

BACKGROUND: The management of neurosurgical disorders has become increasingly specialised. The care of patients with subarachnoid haemorrhage (SAH) has generally been part of core neurosurgical practice, provided by general neurosurgeons whatever their specialist interest. The aim of this present study therefore is to ascertain if, and to what extent care provided by a dedicated neurovascular team (compared to care provided by a general neurosurgical team) change patient disposition in SAH.
METHODS: This is a retrospective analysis of SAH patients, identified from a departmental database of a single neurosurgical centre. In 2008, the service was reorganised such that a neurovascular team cared for all SAH patients. We compared clinical outcome in people admitted prior to this service reorganisation (Period A, 2004-2007) with patients admitted afterwards (Period B, 2009-2011). Survival and recovery were assessed according to the Glasgow Outcome Scale (GOS). Multi-factorial logistic regression analysis was performed to determine the injury and age adjusted incidence of complications, odds of survival at discharge, discharge home, mortality, good recovery (GOS 5) and favourable outcome, by dichotomising GOS (GOS 4-5 vs. GOS 1-3) at 3 months.
RESULTS: 1114 patients were included in the study. The mean age of patients presenting in Period A (n = 543) was younger [50 years (SD 13.5)] than those in Period B (n = 571) [53 years (SD 13)]. Patients admitted in Period B were more likely to present as poor grade (World Federation of Neurological surgeons (WFNS) grades 4 and 5) compared to Period A (26.5% vs. 21.3%). No statistical differences between the groups in the incidence of pre-operative re-bleeding (3% vs. 5%) or rates of delayed cerebral ischaemia (16.1% vs. 16.1%) were observed. After adjustment for age, sex and injury severity, the odds of patient time to discharge, discharge home and good recovery (GOS 5) were 27% (p < 0.001), 45% (p = 0.001) and 93% (p < 0.001) higher respectively in Period B than Period A.
CONCLUSIONS: The data presented here demonstrates that management of SAH by a dedicated neurovascular team improves the potential for patient recovery.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Functional recovery; Neurointensive care; Organisation of stroke care; Outcome measures; Subarachnoid haemorrhage

Mesh:

Year:  2015        PMID: 25839916     DOI: 10.1016/j.clineuro.2015.03.006

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  2 in total

1.  Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Peter Y M Woo; Joanna W K Ho; Natalie M W Ko; Ronald P T Li; Leo Jian; Alberto C H Chu; Marco C L Kwan; Yung Chan; Alain K S Wong; Hoi-Tung Wong; Kwong-Yau Chan; John C K Kwok
Journal:  BMC Neurol       Date:  2020-11-03       Impact factor: 2.474

2.  Clinical characteristics and factors relating to poor outcome in patients with aneurysmal subarachnoid hemorrhage in Vietnam: A multicenter prospective cohort study.

Authors:  Chinh Quoc Luong; Hung Manh Ngo; Hai Bui Hoang; Dung Thi Pham; Tuan Anh Nguyen; Tuan Anh Tran; Duong Ngoc Nguyen; Son Ngoc Do; My Ha Nguyen; Hung Dinh Vu; Hien Thi Thu Vuong; Ton Duy Mai; Anh Quang Nguyen; Kien Hoang Le; Phuong Viet Dao; Thong Huu Tran; Luu Dang Vu; Linh Quoc Nguyen; Trang Quynh Pham; He Van Dong; Hao The Nguyen; Chi Van Nguyen; Anh Dat Nguyen
Journal:  PLoS One       Date:  2021-08-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.